Novobiocin sodium is an antibiotic mainly used in laboratory research rather than clinical treatment. It works by inhibiting bacterial DNA gyrase, an enzyme essential for DNA replication, making it effective against certain Gram-positive bacteria. In microbiology, it is commonly used to differentiate coagulase-negative staphylococci, especially in identifying Staphylococcus saprophyticus, that is resistant to novobiocin, from Staphylococcus epidermidis, that is sensitive. Its clinical use is limited due to toxicity and the availability of safer alternatives. It is grouped under the following drug class(es): PARP Inhibitors. The directory classifies it as a discontinued API with a fermentation-derived source/manufacturing origin. Other names for this substance include Albamycin, Albadry, Cathomycin and Cathomycin sodium. Its PubChem CID is 23663939.
Novobiocin sodium
| CAS No | 1476-53-5 |
|---|---|
| Molecular Formula | C31H35N2NaO11 |
| Molecular Weight | 634.6 g/mol |
| Synonyms | sodium;7-[(2R,3R,4S,5R)-4-carbamoyloxy-3-hydroxy-5-methoxy-6,6-dimethyloxan-2-yl]oxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-4-olate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Novobiocin sodium is an antibiotic mainly used in laboratory research rather than clinical treatment. It works by inhibiting bacterial DNA gyrase, an enzyme essential for DNA replication, making it effective against certain Gram-positive bacteria.
The listed CAS number is 1476-53-5.
The listed molecular formula is C31H35N2NaO11.
The listed molecular weight is 634.6 g/mol.
sodium;7-[(2R,3R,4S,5R)-4-carbamoyloxy-3-hydroxy-5-methoxy-6,6-dimethyloxan-2-yl]oxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-4-olate.
The source lists Albamycin, Albadry, Cathomycin and Cathomycin sodium.